Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.
Cardiac hypertrophy increases the risk of morbidity and mortality of cardiovascular disease and thus inhibiting such hypertrophy is beneficial. In the present study, we explored the effect of a bioactive peptide (PAP) on angiotensin II (Ang II)-induced hypertrophy and associated ventricular arrhythm...
Saved in:
| Main Authors: | Rui Wang, Yanwen Wang, Wee K Lin, Yanmin Zhang, Wei Liu, Kai Huang, Derek A Terrar, R John Solaro, Xin Wang, Yunbo Ke, Ming Lei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0101974 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left ventricular hypertrophy in arterial hypertension and arrhythmia risk
by: I. G. Fomina, et al.
Published: (1970-01-01) -
P21‐Activated Kinase 2 as a Novel Target for Ventricular Tachyarrhythmias Associated with Cardiac Adrenergic Stress and Hypertrophy
by: Tao Li, et al.
Published: (2025-05-01) -
Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias.
by: Xiaowei Chen, et al.
Published: (2017-01-01) -
Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01) -
Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II
by: Yimeng Cui, et al.
Published: (2025-02-01)